Prime Therapeutics proactive prescriber outreach significantly improves statin use in Medicare members with diabetes Largest statin use improvement found when program is coupled with proactive pharmacist outreach News provided by Share this article Share this article EAGAN, Minn., May 11, 2021 /PRNewswire/ -- Using a proactive prescriber outreach program, Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 33 million members nationally, saw increased statin use in Medicare members with diabetes. According to the American Diabetes Association, 34.2 million Americans...